Term
|
Definition
| SERM, mimicks positives of estrogen, improves bone density, risk of DVT, PE, stroke, Category X |
|
|
Term
|
Definition
| Increases excretion of uric acid through the kidneys, flush well with fluids, 2.5 to 3 L a day, patient should not have a history of CHF or be taking Aspirin |
|
|
Term
|
Definition
| Antiinflammory, interupts inflammation process in gout, not with preganancy, causes GI upset |
|
|
Term
|
Definition
| Antiinflammatory, Max dose is 4 grams a day |
|
|
Term
|
Definition
| Biological DMARD, used for RA, inhibits T lymphocytes, not to be used with TNF |
|
|
Term
|
Definition
| Biological DMARD, used for RA, B Lymphocytes, inhibits immune response, Given IV, premedicate with an antihistamine |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Inhibits uric acid formation, If on treatment longer than three years may develop cataracts, also lowers effectiveness of Coumadin |
|
|
Term
|
Definition
| DMARD, used for RA, Gold salt, relieves pain and stiffness, may slow progression, at risk for anemia, cytopenia, and kidney damage |
|
|
Term
|
Definition
| Inhibits absorption from bone, increases excretion though the kidneys |
|
|
Term
|
Definition
| Muscle Relaxant, centrally acting, causes sedation, turns urine a harmless dark green or brown |
|
|
Term
|
Definition
| Muscle relaxant, centrally acting, causes sedation, urine retention, constipation |
|
|
Term
|
Definition
| Bisphosphate, prevents breakdown of the bone, erodes esphogus, take with full glass of water and remain upright for 30 minutes, if painful swallowing or heartburn occurs call the physician |
|
|
Term
|
Definition
| Biological DMARD, TNF, Sub Q, important to rotate sites, often used with Methotrexate |
|
|
Term
|
Definition
| Biological DMARD, TNF, IV, no history of CHF, risk for liver injury |
|
|
Term
|
Definition
| 2nd generation NSAID, Cox 2 inhibitor, No history of heart attack, Decreases inflammation and pain, hard on kidneys, increases risk for MI and stroke |
|
|
Term
| Ibuprofen/Voltaren/Naproxen/Zostrix |
|
Definition
| 1st generation NSAID, general Cox inhibitor, Use: OA, gastric errosion, renal impairment, increase risk for bleeding |
|
|
Term
|
Definition
| Biological DMARD, RA, immunosuppressant, Category X, increased risk for hepatisis, anemia |
|
|
Term
|
Definition
| DMARD, 3 to 6 months for therapeutic response, risk of retinal damage, patient must have eye exams every 6 months |
|
|
Term
|
Definition
| DMARD, not fast acting, RA, GI disturbances and skin irritations |
|
|
Term
|
Definition
| DMARD, RA, not fast acting, 3 to 6 weeks for relief, perserves joint function and decreases progression, monitor liver and kidneys, Category X |
|
|
Term
| Depo Medrol/Solumedrol/Prednisone |
|
Definition
| Corticosteriod, decreases inflammation or suppresses immune response, must be weaned off due to adrenal insuffiency, redistribution of body fat |
|
|
